DF/HCC "Pipelines in Oncology" Seminar - TetraLogic Pharmaceuticals

Date: February 21, 2013 12:30 PM - 02:00 PM
Location: Dana Farber Cancer Institute, 450 Brookline Ave, Yawkey 306
Contact: richard_power@dfci.harvard.edu

TetraLogic Senior Scientists will present on Birinapant, their lead Smac mimetic drug. We will hear from:

David Weng, MD, PhD, Senior Vice President and Chief Medical Officer

Martin Graham, PhD, VP of Development

Stephen M. Condon, PhD, VP of Chemistry

Srinivas Chunduru, PhD, Sr. Director of Biology


Additional Registration Questions

Add additional questions to this event